Skip to Content

ZD 13 (Topiramate 200 mg)

Pill imprint ZD 13 has been identified as Topiramate 200 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; bulimia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate 200 mg ZD 13
Topiramate 200 mg ZD 13
Discount Card Promo
Topiramate
Imprint:
ZD 13
Strength:
200 mg
Color:
White
Size:
12.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0141
Inactive Ingredients:
hypromelloses
magnesium stearate
polyethylene glycol
silicon dioxide
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
microcrystalline cellulose
lactose anhydrous
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0345 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide